Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents (Q71739769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

B St Croix

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

V A Flørenes

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J W Rak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Flanagan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

N Bhattacharya

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J M Slingerland

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R S Kerbel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1204-1210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

Cell and environment interactions in tumor microregions: the multicell spheroid model

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Drug and radiation resistance in spheroids: cell contact and kinetics

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Acquired multicellular-mediated resistance to alkylating agents in cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Multicellular Resistance: A New Paradigm to Explain Aspects of Acquired Drug Resistance of Solid Tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro?

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

A cell cycle-regulated inhibitor of cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Molecular foundations of cancer: New targets for intervention

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustard

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Increased radioresistance of cells in cultured multicell spheroids. II. Kinetic and cytogenetic studies

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Evaluation of breast carcinoma chemosensitivity by flow cytometric DNA analysis and computer assisted image analysis

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

The extracellular matrix as a cell survival factor

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Disruption of epithelial cell-matrix interactions induces apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Apoptosis induced by inhibition of intercellular contact

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Repair of Potentially Lethal Radiation DamageIn VitroandIn Vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Kinetic resistance to anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Confluence-dependent resistance in human colon cancer cells: role of reduced drug accumulation and low intrinsic chemosensitivity of resting cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Antisense oligodeoxynucleotides as clinical therapeutic agents

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

DNA flow cytometry and response to preoperative chemotherapy for primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNM1196-1204

7 January 2021

Identifiers

DOI

10.1038/NM1196-1204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8898746%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference